What pain medication can I take with Brilinta?
Brilinta (ticagrelor) is in a class of drugs known as antiplatelets that is taken twice a day, in the morning and the evening. It is often prescribed for acute coronary syndrome (severe chest pain or after a heart attack) or to help prevent a blood clot formation in a cardiac (heart) stent.
It is also approved to reduce the risk of a first heart attack or stroke in patients with coronary artery disease (CAD) at high risk for such events. It is also used to reduce the risk of stroke in patients with acute ischemic stroke or high-risk transient ischemic attack (TIA).
Your doctor will prescribe a low dose of aspirin to take together with Brilinta (ticagrelor) to help prevent a blood clot. Do not take extra aspirin or NSAIDs like ibuprofen, naproxen or celecoxib for pain relief unless your doctor has directed you to take these medications.
Many nonprescription, over-the-counter (OTC) products contain aspirin, ibuprofen (Advil, Motrin) or naproxen (Aleve). These ingredients can also be found in combination products used for cold or flu symptoms or for sleep. Be sure to check the labels for these ingredients. Ask your pharmacist if you are not sure.
Can I take an opioid pain reliever with Brilinta?
Opioid pain relievers (opioid agonists) may reduce the blood levels and beneficial effects of Brilinta (ticagrelor). Opioid pain relievers include drugs such as hydrocodone, codeine, oxycodone, morphine, and others. Opioids can delay and reduce the absorption of ticagrelor and its active metabolite possibly due to slowed gastric emptying (the stomach doesn't empty as quickly as normal).
Your doctor may be able to prescribe a different type of pain reliever that does not interact with Brilinta. You may also need a dose adjustment, more frequent monitoring, or another type of antiplatelet medication to safely use opioids for pain.
This effect can reduce the beneficial antiplatelet effects of Brilinta. In acute coronary syndrome patients who require an opioid agonist, the use of a parenteral (injectable) antiplatelet agent should be considered.
Bottom Line
Brilinta (ticagrelor) is manufactured by AstraZeneca and was first approved by the FDA in July 2011.
This is not all the information you need to know about Brilinta for safe and effective use. Review the full Brilinta information here, and discuss this information and any questions with your doctor or other health care provider.
Related medical questions
- What foods should I eat or avoid when taking Brilinta?
- Can you drink alcohol while taking Brilinta?
- How long does it take for Brilinta to work?
- How long do I have to take Brilinta after a stent or heart attack?
- What pain medication can I take with Brilinta?
- Is Brilinta a blood thinner or antiplatelet?
- How long should Brilinta be held/stopped before surgery?
- What foods should I eat or avoid when taking Brilinta?
- Can you drink alcohol while taking Brilinta?
- How long does it take for Brilinta to work?
- How long do I have to take Brilinta after a stent or heart attack?
- What pain medication can I take with Brilinta?
- Is Brilinta a blood thinner or antiplatelet?
- How long should Brilinta be held/stopped before surgery?
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions